Ali Khan, BS
Mentor: Munir Tanas, MD
My Research
I was born and raised in Karachi, Pakistan and moved to New York for my undergraduate degree. Given the interdisciplinary nature of today’s research, I explored a variety of fields, including biochemistry, molecular and cell biology, bioinformatics, and even electrical engineering at SUNY Oswego during my undergraduate education. Given my strong interest in cancer signaling, I joined Dr. Tanas’ lab to understand the role of PI3 kinase signaling and Hippo pathway in sarcomagenesis. My long-term goal is to therapeutically target these pathways to improve patient care!
Comprehensive Exam:
Dual Targeting of mTOR and YAP/TAZ in PI3K activated sarcomas
Award:
July 2021- June 2023 Center for Biocatalysis and Bioprocessing Predoctoral Fellowship
Internship:
Summer 2023 Clinica Biomarker Intern at Moderna
Conferences:
- September 28, 2024 University of Iowa Center for Biocatalysis and Bioprocessing Annual Conference; Oral presentation "PI3K regulates TAZ/YAP and mTORC1 and can be synergistically targeted in sarcomas"
- June 18, 2024 HCCC Scientific Retreat; Oral Presentation on “Phosphatidylinositol-3 kinase regulates TAZ and YAP activity in sarcomas: therapeutic implications.”
- May 2024 Center of Biocatalysis and Bioprocessing Spring Symposium; Oral Presentation on “Combination therapy targeting PI3K signaling in sarcomas.”
- April 2024 Moffitt Innovators of Tomorrow Symposium at the Moffit Cancer Center; Oral Presentation on “Therapeutic Targeting of the Phosphatidylinositol 3- Kinase Pathway in Sarcomas.”
- January 2024 HCCC Career Development Seminar Series; “How to Pursue a Clinical Internship in Industry During Your PhD.”
- February 2023 HCCC Northeastern Illinois University; Oral Presentation on “Studying the therapeutic role of YAP/TAZ in sarcomas.”
- August 2022 University of Iowa Sarcoma Research Symposium; Oral Presentation on “Therapeutic approaches to targeting Hippo pathway signaling in sarcomas.
